- Home
- KMI vs COR Comparison
KMI vs COR Comparison
Compare KMI & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMI
- COR
- Stock Information
- Founded
- KMI 1936
- COR 2001
- Country
- KMI United States
- COR United States
- Employees
- KMI N/A
- COR N/A
- Industry
- KMI Natural Gas Distribution
- COR Other Pharmaceuticals
- Sector
- KMI Utilities
- COR Health Care
- Exchange
- KMI Nasdaq
- COR Nasdaq
- Market Cap
- KMI 59.2B
- COR 57.4B
- IPO Year
- KMI 2011
- COR N/A
- Fundamental
- Price
- KMI $27.36
- COR $291.69
- Analyst Decision
- KMI Buy
- COR Buy
- Analyst Count
- KMI 14
- COR 12
- Target Price
- KMI $29.86
- COR $308.83
- AVG Volume (30 Days)
- KMI 11.8M
- COR 1.3M
- Earning Date
- KMI 10-15-2025
- COR 11-05-2025
- Dividend Yield
- KMI 4.27%
- COR 0.75%
- EPS Growth
- KMI 11.35
- COR 5.07
- EPS
- KMI 1.22
- COR 9.68
- Revenue
- KMI $15,969,000,000.00
- COR $316,654,371,000.00
- Revenue This Year
- KMI $11.25
- COR $10.30
- Revenue Next Year
- KMI $5.46
- COR $6.52
- P/E Ratio
- KMI $22.48
- COR $30.44
- Revenue Growth
- KMI 3.97
- COR 11.56
- 52 Week Low
- KMI $21.30
- COR $218.65
- 52 Week High
- KMI $31.48
- COR $309.35
- Technical
- Relative Strength Index (RSI)
- KMI 52.06
- COR 46.95
- Support Level
- KMI N/A
- COR $291.32
- Resistance Level
- KMI $27.81
- COR $307.51
- Average True Range (ATR)
- KMI 0.40
- COR 5.27
- MACD
- KMI -0.88
- COR -0.11
- Stochastic Oscillator
- KMI 98.38
- COR 19.55
About KMI Kinder Morgan Inc.
Kinder Morgan is one of the largest midstream energy firms in the US, with an interest in or an operator on more than 80,000 miles of gas, refined products, and carbon dioxide pipelines. The company also owns one of the largest portfolios of gas and refined products storage and terminals. Most of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.